Skip to content

ARATANA THERAPEUTICS, INC.

CIK 0001509190

← back to feed
Revenue (TTM)
$37.87M
−77.2% YoY Q1 May 2019
Net Income (TTM)
−$12.88M
−197.7% YoY Q1 May 2019
EPS Diluted (TTM)
$0.33
+190.9% YoY Q1 May 2019
Gross Margin
5.6%
Q1 May 2019
Operating Margin
-29.4%
Q1 May 2019
Net Margin
-34.0%
Q1 May 2019
Free Cash Flow (TTM)
−$45.48M
Q1 May 2019
Cash
$36.56M
Q1 May 2019
Total Debt
$36.5M
Q1 May 2019
Shares Outstanding
48.97M sh
Q1 May 2019

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings